Indication
Aviptadil
1 clinical trial
2 products
Clinical trial
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS: A Randomized, Placebo Controlled, Multicenter TrialStatus: Terminated, Estimated PCD: 2023-06-14
Product
AviptadilProduct
Placebo 0.9% NaCl solution